Drug-drug interactions between vitamin K antagonists and statins: a systematic review Anna E. EngellAndreas L. O. SvendsenAnton Pottegård Review 24 April 2021 Pages: 1435 - 1441
Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review Miki Ohta Review 07 April 2021 Pages: 1443 - 1452
Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled trials Yao Hao TeoCeline Shuen Yin YoongChing-Hui Sia Review 03 May 2021 Pages: 1453 - 1464
Direct oral anticoagulant safety during breastfeeding: a narrative review Maryam DaeiHossein KhaliliZinat Heidari Review 08 May 2021 Pages: 1465 - 1471
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9 Markus ZeitlingerMartin BauerGünther Staffler Clinical Trial Open access 10 May 2021 Pages: 1473 - 1484
The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis Shanshan XieJingjing ChenWeifang Zhang Pharmacodynamics 03 August 2021 Pages: 1485 - 1494
Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars Samuel AzuzMax NewtonBirgitte Klindt Poulsen Pharmacoeconomics Open access 18 May 2021 Pages: 1495 - 1501
A cross-sectional study of chemotherapy-related AKI Xin KangXizi ZhengLi Yang Pharmacoepidemiology and Prescription 15 May 2021 Pages: 1503 - 1512
Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase Diego Macías Saint-GeronsRafael Tabarés-Seisdedos Pharmacoepidemiology and Prescription 03 May 2021 Pages: 1513 - 1521
Association between the use of hormonal contraceptives and risk of cholecystectomy in women of reproductive age Farzin Khosrow-KhavarMohit SodhiMahyar Etminan Pharmacoepidemiology and Prescription 10 May 2021 Pages: 1523 - 1529
The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions M. ReumermanJ. TichelaarM. A. van Agtmael Pharmacoepidemiology and Prescription Open access 12 May 2021 Pages: 1531 - 1542
Unexpected beneficial effects of drugs: an analysis of cases in the Dutch spontaneous reporting system Florence van HunselCorine Ekhart Pharmacoepidemiology and Prescription 21 April 2021 Pages: 1543 - 1551
Trends and patterns in EU(7)-PIM prescribing to elderly patients in Germany Iva Selke KrulichováGisbert W. SelkePetra A. Thürmann Pharmacoepidemiology and Prescription 03 May 2021 Pages: 1553 - 1561
Effectiveness of fondaparinux vs unfractionated heparin following percutaneous coronary intervention in survivors of out-of-hospital cardiac arrest due to acute myocardial infarction Leonardo De LucaMassimo UguccioniFrancesco Musumeci Pharmacoepidemiology and Prescription 08 May 2021 Pages: 1563 - 1567
Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study Sarah BitarNathalie ThillyNelly Agrinier Pharmacoepidemiology and Prescription 10 May 2021 Pages: 1569 - 1581
Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis Massimo TempestilliGiulia Valeria StaziChiara Agrati Letter to the Editor 12 May 2021 Pages: 1583 - 1585
Drugs and Dupuytren’s disease: a pharmacovigilance study in VigiBase® Jean-Louis MontastrucJulia Guion-FirminAgnès Sommet Letter to the Editor 29 April 2021 Pages: 1587 - 1588
Duplicate prescriptions—proposal of a clinically oriented categorisation Johannes HeckBenjamin KrichevskyOlaf Krause Letter to the Editor Open access 23 April 2021 Pages: 1589 - 1591
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials Farhad PazanMirko PetrovicMartin Wehling Correction Open access 07 August 2021 Pages: 1593 - 1594
Correction to: Calling for an exponential escalation scheme in vaccine development for COVID-19 Martin Wehling Correction 24 August 2021 Pages: 1595 - 1595